| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥1092.6B | ¥987.6B | +10.6% |
| Operating Income | ¥57.2B | ¥46.0B | +24.4% |
| Ordinary Income | ¥58.4B | ¥47.2B | +23.7% |
| Net Income | ¥40.2B | ¥32.7B | +23.0% |
| ROE | 7.0% | 6.1% | - |
FY2026 Q2 results demonstrate robust growth with Revenue of 109.3B yen (YoY +10.6%), Operating Income of 5.7B yen (+24.4%), Ordinary Income of 5.8B yen (+23.7%), and Net Income of 4.0B yen (+23.0%). Operating margin expanded to 5.23% from 4.65% YoY, representing a 58 basis point improvement driven by gross margin enhancement and operating leverage. Progress toward full-year guidance appears solid, with first-half revenue at 49% and operating income at 52% of annual targets of 221.2B yen and 11.1B yen respectively. Profitability improvement stems from category mix optimization and scale efficiencies, though capital efficiency metrics including ROIC around 5% remain areas for enhancement. Operating cash flow of 7.5B yen represents 1.86 times net income, though free cash flow of negative 2.4B yen reflects accelerated growth investment with capital expenditure of 9.8B yen at 2.9 times depreciation.
[Profitability] ROE of 7.0% shows improvement from prior period of 6.1%, reflecting net margin expansion of 37 basis points to 3.68% alongside revenue growth. Operating margin of 5.23% improved 58 basis points from 4.65% YoY, driven by gross margin improvement to 20.4% and SG&A ratio reduction by 35 basis points to 15.16%, demonstrating positive operating leverage as expense growth of 8.1% trailed revenue growth of 10.6%. ROA of 3.0% reflects asset turnover of 0.813 times and improved net margin. Interest coverage measured as operating income to interest expense stands at 44.7 times, providing substantial cushion. [Cash Quality] Cash and deposits of 4.7B yen cover short-term borrowings of 1.2B yen by 3.8 times. Operating cash flow of 7.5B yen represents 1.86 times net income, indicating strong cash conversion. However, inventory buildup of 16.4B yen absorbed working capital during the period. [Investment Efficiency] Total asset turnover of 0.813 reflects inventory-intensive retail operations. Inventory of 28.4B yen increased 6.1% YoY while accounts payable of 28.1B yen increased 5.2%, maintaining negative working capital structure. Capital expenditure of 9.8B yen at 2.9 times depreciation of 3.4B yen signals accelerated store expansion and renovation investment. [Financial Health] Equity ratio of 42.9% improved from 42.0% YoY. Current ratio of 89.1% and quick ratio of 28.9% indicate tight short-term liquidity, though supported by negative working capital model. Debt-to-equity ratio of 1.33 and debt-to-capital of 31.5% remain within acceptable ranges. Debt-to-EBITDA of 2.91 times appears moderately elevated during growth phase, though mitigated by substantial interest coverage.
Operating cash flow of 7.5B yen represents 1.86 times net income, confirming cash-backed earnings quality. Within operating activities, inventory increase of 17.0B yen absorbed cash as the company builds stock for growth and seasonal demand, partially offset by accounts payable increase of 13.8B yen that leverages supplier credit. Investing cash flow of 9.8B yen primarily consisted of capital expenditure for store expansion and renovation at 2.9 times depreciation, indicating accelerated growth investment. Free cash flow of negative 2.4B yen results from this frontloaded investment rather than operational weakness. Financing activities included dividend payments of approximately 0.4B yen and net debt reduction, with long-term borrowings decreasing 5.9B yen while current portion increased 3.7B yen, suggesting scheduled amortization. Cash position decreased 1.5B yen to 4.7B yen, reflecting the net impact of growth investment exceeding operating cash generation in this expansion phase. The operating CF to EBITDA ratio of 0.82 falls below the 0.9 benchmark primarily due to working capital absorption, while the OCF coverage of dividends exceeds 18 times, indicating sustainable distribution capacity.
Ordinary income of 5.8B yen versus operating income of 5.7B yen shows net non-operating contribution of approximately 0.1B yen, representing minimal impact from non-core activities. Non-operating expenses of 1.3B yen primarily consist of interest expense, while non-operating income offsets this burden, maintaining earnings quality centered on core operations. Non-operating items represent roughly 0.1% of revenue, indicating earnings derive substantially from business operations rather than financial engineering or one-time gains. The composition shows interest expense coverage of 44.7 times by operating income, confirming manageable financial costs relative to operational profitability. Operating cash flow of 7.5B yen exceeding net income of 4.0B yen by 1.86 times demonstrates earnings convert effectively to cash despite working capital absorption from inventory buildup. The inventory increase of 16.4B yen aligns with revenue growth of 10.6%, suggesting operational rather than quality deterioration, though monitoring turnover rates remains prudent. Accounts payable growth of 13.8B yen tracking inventory buildup indicates consistent working capital management without aggressive extension of payment terms that might signal liquidity stress.
Inventory accumulation of 16.4B yen carries risk of markdown pressure and gross margin erosion if demand softens or product mix proves suboptimal, potentially reversing the 58 basis point operating margin gain. Accelerated store expansion with capital expenditure at 2.9 times depreciation creates exposure to site selection errors or market cannibalization that could delay investment payback and pressure return on invested capital currently around 5%. Short-term liquidity metrics with current ratio of 89.1% and quick ratio of 28.9% leave limited buffer for working capital volatility or unexpected cash needs, particularly given seasonal inventory requirements and store opening schedules. Competitive intensity in the drugstore sector may compress gross margins through promotional activity or necessitate increased SG&A spending to defend market position, challenging the current 5.2% operating margin. Asset retirement obligations of 3.9B yen will generate future cash outflows as the store network matures, requiring allocation of operating cash flow to non-growth purposes.
[Industry Position] (Reference - Proprietary Analysis) The company's operating margin of 5.2% in FY2026 demonstrates improving operational efficiency within the drugstore retail sector. Historical trajectory shows operating margin expansion from previous levels, with the current 5.2% representing a 58 basis point YoY improvement. Revenue growth of 10.6% YoY reflects solid market share gains and store network expansion, supported by same-store productivity improvements. Net profit margin of 3.7% in FY2026 indicates effective cost management and operational leverage, though return on equity of 7.0% suggests room for capital efficiency enhancement relative to growth investment intensity. The company's growth investment posture with CapEx at 2.9 times depreciation positions it as an expansion-oriented player, trading near-term free cash flow for future revenue and profit contribution. Financial leverage measured by debt-to-equity of 1.33 and equity ratio of 42.9% appears moderate for a growth-stage retailer, balancing funding needs against balance sheet stability. The negative working capital structure with accounts payable closely matching inventory demonstrates industry-typical supplier credit optimization, common among high-volume retailers with strong purchasing positions.
Operating margin expansion to 5.23% with 58 basis point YoY improvement driven by gross margin enhancement and SG&A leverage demonstrates successful execution of efficiency initiatives and category mix optimization, with first-half progress at 52% of full-year operating income guidance suggesting achievable annual targets. Capital allocation strategy prioritizes growth investment with CapEx at 2.9 times depreciation generating negative 2.4B yen free cash flow, positioning the company in expansion mode where near-term cash conversion is subordinated to future revenue and profit contribution from new store openings. Return on capital metrics including 7.0% ROE and estimated 5% ROIC indicate improvement trajectory but highlight capital efficiency as the key operational focus, requiring enhanced store-level productivity and inventory turnover to justify elevated investment intensity and achieve sustainable value creation beyond scale expansion.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.